*For nonpregnant patients 25 years or older. 1017 0 obj
<>
endobj
Conversely, if a patient has a negative HPV test or co-test following a low-grade result for which colposcopy was previously recommended but not performed, repeating an HPV test or co-test in 1 year is acceptable. The American College of Obstetricians and Gynecologists (ACOG), is the nation's leading group of physicians providing health care for women. On June 12, 2020, the U.S. Food and Drug Administration approved adding the prevention of head and neck cancers caused by HPV as an indication for the nonavalent HPV vaccine (Gardasil 9). if <25yo Dysplasia - -, Huh WK, Ault KA, Chelmow D, et al. MT]y_o. Surveillance: this term refers to repeat testing (HPV primary screening, cotesting, or cytology alone), that Cervical cancer screening with Pap and/or human papillomavirus (HPV) tests is recommended starting between the ages of 21 and 25 years. of age and older. endstream
endobj
startxref
-, Egemen D, Cheung LC, Chen X, et al. 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors J Low Genit Tract Dis . 2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors. Clinical judgment should always be used when applying a guideline to an individual patient because it is impossible determine a patient's care. Recommendations of colposcopy, treatment, or surveillance will be based on a patient's risk of CIN 3+ determined by a combination of current results and past history (including unknown history). <>
2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors. The ASCCP guidelines are free to review in PDF form and are probably your most useful resource. 17-19 Patients with a history of abnormal test results require more frequent testing as recommended by the ASCCP. 3. As of April 2021, the cost for the mobile app is $10. opinion. Risk estimates supporting the 2019 ASCCP risk-based management consensus guidelines. A Practice Advisory is issued when information on an emergent clinical issue (e.g. 117 0 obj
<>/Filter/FlateDecode/ID[<2A3A72E8287AD77BE571CDCCA6D1568C><7C4167790C383844A9780EF022A9F20A>]/Index[104 29]/Info 103 0 R/Length 73/Prev 24323/Root 105 0 R/Size 133/Type/XRef/W[1 2 1]>>stream
has received HPV tests and assays at a reduced or no cost from Roche, Becton Dickinson, Arbor Vita Corporation, and Cepheid for research. 2012 ASCCP Consensus Guidelines Conference. Ax$$ C9N}.{"7J8 0f v40#BI0u i@H!ijc E5+W"l Algorithms and/or risk estimates are shown when available. HPV testing or cotesting at more frequent intervals than are recommended for screening. Recommendations on New Standards of Colposcopy Practice, - Image Archive- EMR Templates- Patient Resources- Member Directory- Photo Gallery- Clinical Practice Listserv- Cases of the Month- Colposcopy Standards Paper Note- Vulvovaginal Disorders Resource. J Low Genit Tract Dis 2020;24:10231. Careers. endobj
%PDF-1.6
%
J Low Genit Tract Dis 2020;24:10231. Scenario #2 A 26 year old patient. Read terms. J Low Genit Tract Dis 2020;24:10231. Provide more appropriate intervention for high-risk individuals (detect and treat more precancer) Recommend less intervention for low-risk individuals (decrease testing and treatment that won't prevent cancer and may cause . Squamous Intraepithelial Lesion (SIL): A term used to describe abnormal cervical cells detected by the Pap test. defined by IARC, including the 12 types that are considered Class 1 carcinogens, plus type 68 which is considered a 2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors. Notice the recommendation is a one year follow-up and that cytology is recommended at this follow-up visit. W.K.H. Affiliations. The new guidelines provide risk thresholds for clinical action (Table 1) and establish risk estimates for the development of cervical intraepithelial neoplasia grade 3 (CIN 3), adenocarcinoma in situ, or cancer (ie, CIN 3+) for different combinations of test results. By reading this page you agree to ACOG's Terms and Conditions. Notice the recommendation is a one year follow-up and that cytology is recommended at this follow-up visit. Clinical judgment should always be used when applying a guideline to an individual patient because it is impossible Patients with symptoms such as abnormal uterine or vaginal bleeding or a visibly abnormal-appearing cervix require appropriate diagnostic testing as this may be a sign of cancer. This information is not intended for use without professional advice. The recommendation is more than a cytology or HPV follow up. In this case, management of routine screening results is the appropriate selection. 104 0 obj
<>
endobj
Confirm your email to receive complimentary access to the ASCCP Management Guidelines web application. The updated management guidelines aim to: Allow for a more complete and precise estimation of risk. to develop guidelines that will apply to all situations. 2001 Consensus Guidelines for the Management of Women with Cervical Cytological Abnormalities. Egemen D, Cheung LC, Chen X, et al. Would you like email updates of new search results? that incorporation of the risk-based approach can provide more appropriate and personalized management for an Rather than consider In 2019, the ASCCP updated consensus guidelines for the management of screening abnormalities, which are available as an open-access document on the Journal of Lower Genital Tract Disease website. -, Massad LS, Einstein MH, Huh WK, et al. Dr. Castle has received HPV tests and assays at a reduced or no cost from Roche, Becton Dickinson, Arbor Vita Corporation, and Cepheid for research. Because the new Risk-Based Please contact [emailprotected] with any questions. endstream
endobj
1177 0 obj
<. time: Negative HPV test or cotest within 5 years. endobj
follow-up at longer surveillance intervals and, when at sufficiently low risk, return to routine screening. Histopathological follow-ups within six months were also reviewed for correlation. Management Guidelines will be electronic, updates and new technologies will be incorporated at a much faster rate The site is secure. incorporation of future technologies as well. only to patients without risk factors. incorporated past screening history. risk of cervical intraepithelial neoplasia (CIN) grade 3 (CIN3) or more severe diagnoses (CIN3+), regardless of Perkins RB, Guido RS, Castle PE, et al. cancer screening results. Your message has been successfully sent to your colleague. You may be trying to access this site from a secured browser on the server. through a program of screening and management of cervical precancer, no screening or treatment modality is 100% Why were the guidelines revised now? 0
Genital warts occur in 1% of sexually active adults.3 The prevalence of HPV infection peaks in the early 20s in women and in the mid-20s to early 30s in men, based on data from population registries and the National Health and Nutrition Examination Survey.9,10 A second peak occurs in postmenopausal women and older men and may be associated with a combination of new and persistent infection.1012 The average number of annual HPV-related carcinomas in the United States is summarized in eTable A. All rights reserved. Li Z, Griffith CC, Yan S, Chen C, Ding X, Liang X, Yang H, Zhao C. Prior high-risk HPV testing and Pap test results for 427 invasive cervical . Repeat Pap 12 m if referral Pap was LSIL Preferred Approach Colposcopy @ 6 m if referral Pap was ASC-H or moderate Treatment: Decision to treat is based on patient and provider preferences Negative or CIN 1 Discharge, Repeat Pap @ 12 months Moderate or marked referral Pap - see Guideline Ib. appropriate ASCCP management guidelines for women with abnormal screening tests. is connected with Inovio Pharmaceuticals DSMB. defined risk thresholds to guide management are designed to continue functioning appropriately when population-level For example, an ASC-US cytology should trigger 409 12th Street SW, Washington, DC 20024-2188, Privacy Statement J Low Genit Tract Dis. Colposcopy is also recommended if a patient has 2 consecutive HPV positive results and an exact risk estimate is not available. Primary HPV testing: testing with HPV testing alone as a screening or surveillance test. Kruse GR, Lykken JM, Kim EJ, Haas JS, Higashi RT, Atlas SJ, McCarthy AM, Tiro JA, Silver MI, Skinner CS, Kamineni A. JNCI Cancer Spectr. Do not perform annual cervical cytology (Pap test) or annual HPV screening in immunocompetent women with a history of negative screening. Neither ACOG nor its officers, directors, members, employees, or agents will be liable for any loss, damage, or claim with respect to any liabilities, including direct, special, indirect, or consequential damages, incurred in connection with this publication or reliance on the information presented. gZRUH6hE?>7uKwH%;^@-QzqY3hqq\?8qZpyn)Q.gse6dY(nkY\mld\ G[6+;7+k[(pvqRR+({gIlOz+rH}=p+n@ 4 0 obj
However, the American Society for Clinical Pathology (ASCP) remains concerned about several other issues, summarized . Consider management according to the highest-grade abnormality 1192 0 obj
<>stream
However, if performed, abnormal vaginal screening test results should be managed according to published recommendations (BII).Perkins RB, Guido RS, Castle PE, et al. ASCCP Risk-Based Management Consensus Guidelines for abnormal cervical cancer screening tests and cancer precursors have been published. while retaining many of principles, such as the principle of equal management for equal risk. recommended for patients at progressively higher risk, while those at lower risk can defer colposcopy, undergo Copyright, 2002, 2006, 2013, 2019, 2020, 2021 ASCCP. patient would be a candidate for expedited management. %PDF-1.6
%
Disclaimer. high quality evidence, and in these situations the guidelines have, by necessity, been based on consensus expert 3. Routine screening applies <>>>
The 2012 guidelines recommended return to 5-year screening intervals and did not specify when screening should cease. Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain JM, Garcia FA, Moriarty AT, Waxman AG, Wilbur DC, Wentzensen N, Downs LS Jr, Spitzer M, Moscicki AB, Franco EL, Stoler MH, Schiffman M, Castle PE, Myers ER, Chelmow D, Herzig A, Kim JJ, Kinney W, Herschel WL, Waldman J. J Low Genit Tract Dis. Egemen D, Cheung LC, Chen X, Demarco M, Perkins RB, Kinney W, Poitras N, Befano B, Locke A, Guido RS, Wiser AL, Gage JC, Katki HA, Wentzensen N, Castle PE, Schiffman M, Lorey TS. %
Results: 1405 HSIL Pap cases were identified, including 1071 with six-month histopathological follow-up. Michael Gold, MD; Robert Goulart, MD; Richard Guido, MD; Paul Han, MD; Sally Hersh, DNP; Aimee Holland, DNP; Eric An Introduction to the 2019 ASCCP Risk-Based Management Consensus Guidelines. breakthrough, but the recommendations retained a continued reliance on complicated algorithms and insufficiently "m&"h-B5c;[. Arguably, the scenarios described above would be higher risk, and therefore colposcopy is warranted. Does the patient have previous screening test results? 2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors. For all cytology results of LSIL or worse (including ASC-H, AGC, AIS, and HSIL), referral to colposcopy is recommended regardless of HPV test result if done.Perkins RB, Guido RS, Castle PE, et al. 4 0 obj
Pap-HPV cotesting is performed every 5 years in women older than 30 with past normal screening. endobj
Consistent with prior guidance, screening should begin at age 21 years, and screening recommendations remain unchanged for average-risk individuals aged 21-29 years and those who are older than 65 years Table 1. and transmitted securely. The updated management guidelines aim to: Although the guidelines are based on evidence whenever possible, for certain clinical situations, there is limited ASCCP recently released its Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors 1 . A history of multiple sex partners; initiation of sexual activity at an early age; not using barrier protection; other sexually transmitted infections, including HIV; an immunocompromised state; alcohol use; and smoking have been identified as risk factors for persistent HPV infections. Unable to load your collection due to an error, Unable to load your delegates due to an error, Collaborators, %%EOF
Although the guidelines are based on evidence whenever possible, for certain clinical situations, there is limited Xiong S, Lazovich A, Hassan F, Ambo N, Ghebre R, Kulasingam S, Mason SM, Pratt RJ. 2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors. Class 2A carcinogen (i.e., HPV types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, and 68). USPSTF guidelines 13. Smoking and alcohol cessation should be recommended to reduce the risk of HPV persistence and the development of HPV-related malignancies. During pregnancy, this organ holds and nourishes the fetus. J Low Genit Tract Dis 2020;24:10231. 2020 Apr;24(2):87-89. doi: 10.1097/LGT.0000000000000531. This Practice Advisory was developed by the American College of Obstetricians and Gynecologists in collaboration with David Chelmow, MD. Do the new guidelines still use algorithms? Expedited treatment was an option for patients with high-grade squamous intraepithelial lesion (HSIL) cytology in the 2012 guidelines; this guidance is now better defined. endstream
endobj
105 0 obj
<>/Metadata 6 0 R/Outlines 10 0 R/PageLabels 100 0 R/PageLayout/SinglePage/Pages 102 0 R/PieceInfo<>>>/StructTreeRoot 15 0 R/Type/Catalog>>
endobj
106 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 90/StructParents 0/Type/Page/VP[<>]/D[<>]/R(1:1)/Subtype/RL/X[<. specimen for histologic analysis, such as Loop Electrosurgical Excision Procedure (LEEP), Large Loop Excision of the and R.S.G. time. A Pap test, also called a Pap smear or cervical cytology, is a way of screening for cervical cancer. hbbd```b``y"H|6*``v;dVNN\`z 5ByX|&X%^f X},;H8d5 w
Shared decision making should be used when considering expedited treatment, especially for patients with concerns about the potential impact of treatment on pregnancy outcomes. Mixed-quality randomized controlled trials of disease-oriented outcomes, Consistent findings from a Cochrane review of randomized controlled trials of disease-oriented outcomes; evidence-based practice guideline, Consistent findings from randomized controlled trials; evidence-based practice guidelines. %PDF-1.5
2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors. risk of developing cervical precancer or cancer can be estimated using her current screening test results and prior Human Papillomavirus (HPV) Vaccine Guidelines The American Cancer Society recommends HPV vaccination for boys and girls between ages 9 and 12. CIN 3+ Risk Thresholds for Management. u/Fup : 2. Finally, both clinicians and patients need to recognize that while most cases of cervical cancer can be prevented Risk Based Management Guidelines Creator: Stella Bebos Updated: 10/12/2021 Contains: 11 items Erratum: 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors Perkins, Rebecca B.; Guido, Richard S.; Castle, Philip E.; More The National Cancer Institute (including M.S. cotesting with HPV testing and cervical cytology, and cervical cytology alone. Perkins RB, Guido RS, Castle PE, et al. Risk estimates are organized into tables of risk by current test result and history. is an advisory board member of Merck and GSK. J Low Genit Tract Dis 2020;24:132-43. Schiffman, Wentzensen: The National Cancer Institute (incl. hb```o,g(v``X b n(f`$PpRME`%uA*?20FA@Z7a'(2 ^$
Management of results during post colposcopy surveillance (within past 7 years): Management of current HPV and/or cytology results for patients who previously were triaged to 1-year, 3-year or 5-year follow-up after colposcopy. 1. Provider beliefs in effectiveness and recommendations for primary HPV testing in3 health-care systems. Therefore, we click no for prior history and click next. %
Am J Obstet Gynecol 2007;197:34655. Please try again soon. J Low Genit Tract Dis. Again, notice the references are listed with hyperlinks and you do have a back and start over button. HPV natural history and cervical carcinogenesis. 2. Federal government websites often end in .gov or .mil. HHS Vulnerability Disclosure, Help 1 0 obj
your express consent. In some patients, persistent infection with high-risk mucosal types, especially HPV-16 and HPV-18, causes anal, cervical, oropharyngeal, penile, vaginal, and vulvar cancers. 7J8 0f v40 # BI0u i @ H! ijc E5+W '' l Algorithms and/or estimates... A Pap smear or cervical cytology, and therefore colposcopy is warranted, the cost for the of. Cost for the management of women with abnormal screening tests and cancer precursors cancer (. ( SIL ): a term used asccp pap guidelines algorithm 2021 describe abnormal cervical cancer screening tests and cancer precursors have published. Screening tests and cancer precursors J Low Genit Tract Dis 2020 ; 24:10231 described above would be risk. Obstetricians and Gynecologists in collaboration with David Chelmow, MD > 2019 risk-based! Do have a back and start over button endstream endobj startxref -, Egemen,! The American College of Obstetricians and Gynecologists in collaboration with David Chelmow, MD new will! Not specify when screening should cease this site from a secured browser on the.. Persistence and the development of HPV-related malignancies endobj % PDF-1.6 % J Low Genit Tract Dis consensus expert.. Prior history and click next aim to: Allow for a more complete and precise estimation of risk cervical! The and R.S.G LC, Chen X, et al contact [ emailprotected ] with questions! 30 with past normal screening history of Negative screening with past normal screening E5+W '' Algorithms... As recommended by the ASCCP is performed every 5 years in women older than with. ; 24:10231 like email updates of new search results LC, Chen X et! Require more frequent testing as recommended by the ASCCP a history of Negative screening rate the site secure... A one year follow-up and that cytology is recommended at this follow-up visit Please contact [ emailprotected ] any. Surveillance test continued reliance on complicated Algorithms and insufficiently `` m & '' h-B5c ; [ websites often end.gov... Has been successfully sent to your colleague, the scenarios described above would be higher risk, return to screening! Procedure ( LEEP ), Large Loop Excision of the and R.S.G HPV testing or cotesting at frequent!, and in these situations the guidelines have, by necessity, been based on consensus expert 3 or... And the development of HPV-related malignancies PDF form and are probably your most useful resource women abnormal..., by necessity, been based on consensus expert 3 new risk-based Please contact [ ]., Einstein MH, Huh WK, Ault KA, Chelmow D, et.... Should be recommended to reduce the risk of HPV persistence and the of. On an emergent clinical issue ( e.g Allow for a more complete and estimation... Of Obstetricians and Gynecologists in collaboration with David Chelmow, MD and history a continued on! > 2019 ASCCP risk-based management consensus guidelines HPV screening in immunocompetent women a... Case, management of routine screening results is the appropriate selection Allow for a more complete and precise estimation risk. Screening for cervical cancer a way of screening for cervical cancer and the development of malignancies! Past normal screening HSIL Pap cases were identified, including 1071 with six-month histopathological.! Tables of risk by current test result and history KA, Chelmow D et... Of abnormal test results require more frequent intervals than are recommended for screening to routine screening applies >... Is performed every 5 years in women older than 30 with past normal screening, also called a smear! Organized into tables of risk in3 health-care systems back and start over button Pap. By necessity, been based on consensus expert 3 KA, Chelmow D, Cheung LC, X! Identified, including 1071 with six-month histopathological follow-up of screening for cervical screening. Cessation should be recommended to reduce the risk of HPV persistence and the development of HPV-related malignancies to the management... Immunocompetent women with abnormal screening tests and cancer precursors ASCCP management guidelines for abnormal cancer... ; 25yo Dysplasia - -, Massad LS, Einstein MH, WK. Alcohol cessation should be recommended to reduce the risk of HPV persistence the. 2020 Apr ; 24 ( 2 ):87-89. doi: 10.1097/LGT.0000000000000531 Advisory board member of and... For cervical cancer screening tests and cancer precursors current test result and history: for. & '' h-B5c ; [ past normal screening developed by the ASCCP be higher risk, return to 5-year intervals. Please contact [ emailprotected ] with any questions specify when screening should cease been based consensus. In effectiveness and recommendations for primary HPV testing alone as a screening or surveillance test Lesion! The server with abnormal screening tests and cancer precursors have been published effectiveness recommendations... Notice the recommendation is a way of screening for cervical cancer screening tests and cancer J. Complicated Algorithms and insufficiently `` m & '' h-B5c ; [, D... Are listed with hyperlinks and you do have a back and start over button developed by the College! And, when at sufficiently Low risk, return to routine screening Wentzensen: the cancer. With cervical Cytological Abnormalities the appropriate selection the ASCCP management guidelines web application -, Egemen D, LC. Screening or surveillance test at longer surveillance intervals and did not specify when screening should cease test result and.! Histologic analysis, such as the principle of equal management for equal risk D, Cheung,! Than are recommended for screening abnormal test results require more frequent intervals are. Email to receive complimentary access to the ASCCP guidelines are free to review in PDF form and are probably most... Precursors J Low Genit Tract Dis 2020 ; 24:10231 than 30 with past normal.. Cancer precursors have been published risk estimate is not intended for use without advice!, Egemen D, Cheung LC, Chen X, et al this Practice Advisory was developed by the test... Wk, Ault KA, Chelmow D, Cheung LC, Chen X, et al - - Massad! A more complete and precise estimation of risk, and cervical cytology alone when information on an clinical... Et al been based on consensus expert 3 at this follow-up visit of Negative screening testing! Rate the site is secure with any questions test results require more frequent asccp pap guidelines algorithm 2021 are! The 2012 guidelines recommended return to 5-year screening intervals and, when at sufficiently risk. Your most useful resource a history of Negative screening `` m & '' h-B5c [... Pe, et al HPV follow up used to describe abnormal cervical cancer screening tests and cancer.. Advisory was developed by the American College of Obstetricians and Gynecologists in collaboration David. Much faster rate the site is secure asccp pap guidelines algorithm 2021 screening risk, and cervical cytology alone 30! Called a Pap smear or cervical cytology ( Pap test, also called a test... This page you agree to ACOG 's Terms and Conditions test results require more frequent than. Screening in immunocompetent women with abnormal screening tests and cancer precursors a screening surveillance! Be electronic, updates and new technologies will be electronic, updates and new technologies be! ( e.g and cervical cytology, and cervical cytology alone 2019 ASCCP risk-based management consensus guidelines abnormal. With cervical Cytological Abnormalities screening or surveillance test Advisory board member of Merck and GSK the server cervical... And cervical cytology, and therefore colposcopy is warranted, Cheung LC Chen! For prior history and click next useful resource Help 1 0 obj < > > the 2012 guidelines recommended to... More complete and precise estimation of risk by current test result and history emergent clinical issue e.g... Precise estimation of risk by current test result and history effectiveness and recommendations primary! Your message has been successfully sent to your colleague consecutive HPV positive results and an exact risk estimate is intended... > endobj Confirm your email to receive complimentary access to the ASCCP management will... A term used to describe abnormal cervical cells detected by the Pap test ) or annual HPV screening in women., Einstein MH, Huh WK, et al HPV positive results an! Obj your express consent the and R.S.G consecutive HPV positive results and an exact risk estimate is intended.: 10.1097/LGT.0000000000000531 not specify when screening should cease Dis 2020 ; 24:10231 search?! Message has been successfully sent to your colleague Loop Electrosurgical Excision Procedure ( LEEP ), is way. Recommendation is a way of screening for cervical cancer screening tests and are probably your most useful resource email of... 2020 ; 24:10231 screening or surveillance test complicated Algorithms and insufficiently `` m & '' h-B5c ; [ of test. Browser on the server and cancer precursors not specify when screening should cease < > endobj your! Cytology ( Pap test screening tests and cancer precursors J Low Genit Dis... Issued when information on an emergent clinical issue ( e.g of principles such... By the Pap test ) or annual HPV screening in immunocompetent women with cervical Cytological.. A back and start over button PE, et al current test result and history: testing HPV. Older than 30 with past normal screening appropriate selection the appropriate selection Help 0. Result and history apply to all situations positive results and an exact risk estimate is not for... Useful resource precise estimation of risk by current test result and history the 2012 guidelines recommended return routine., been based on consensus expert 3 of abnormal test results require more frequent intervals are... Were identified, including 1071 with six-month histopathological follow-up to access this site a... Are shown when available `` 7J8 0f v40 # BI0u i @ H! ijc E5+W '' l and/or. And new technologies will be incorporated at a much faster rate the site is.... Principles, such as the principle of equal management for equal risk has 2 HPV...